343 related articles for article (PubMed ID: 15991596)
1. Studies on post-transplant dyslipidemia in kidney transplant patients.
Marubayashi S; Ohdan H; Tashiro H; Tokita D; Onoe T; Hayamizu K; Asahara T; Doi S; Okumoto S; Tanji C; Kawai T; Taniguchi Y; Fukuda Y; Dohi K
Hiroshima J Med Sci; 2005 Jun; 54(2):39-45. PubMed ID: 15991596
[TBL] [Abstract][Full Text] [Related]
2. Impact of fluvastatin on hyperlipidemia after renal transplantation.
Tokumoto T; Tanabe K; Ishida H; Shimmura H; Ishikawa N; Goya N; Akiba T; Toma H
Transplant Proc; 2004 Sep; 36(7):2141-4. PubMed ID: 15518777
[TBL] [Abstract][Full Text] [Related]
3. A long-term study on hyperlipidemia in stable renal transplant recipients.
Tse KC; Lam MF; Yip PS; Li FK; Lai KN; Chan TM
Clin Transplant; 2004 Jun; 18(3):274-80. PubMed ID: 15142048
[TBL] [Abstract][Full Text] [Related]
4. Hyperlipidemia in long-term survivors of pediatric renal transplantation.
Sharma AK; Myers TA; Hunninghake DB; Matas AJ; Kashtan CE
Clin Transplant; 1994 Jun; 8(3 Pt 1):252-7. PubMed ID: 8061364
[TBL] [Abstract][Full Text] [Related]
5. Renal function and lipid metabolism in pregnant renal transplant recipients.
Czajkowski K; Wójcicka-Bentyn J; Sieńko J; Grymowicz M; Smolarczyk R; Malinowska-Polubiec A; Romejko E
Eur J Obstet Gynecol Reprod Biol; 2004 Jun; 114(2):155-61. PubMed ID: 15140508
[TBL] [Abstract][Full Text] [Related]
6. Disturbed lipids, lipoproteins and triglyceride-rich lipoproteins as well as fasting and nonfasting non-high-density lipoprotein cholesterol in post-renal transplant patients.
Kimak E; Ksiazek A; Baranowicz-Gaszczyk I; Solski J
Ren Fail; 2007; 29(6):705-12. PubMed ID: 17763166
[TBL] [Abstract][Full Text] [Related]
7. Correlation of C0 and C2 levels with lipid profiles in adolescent renal transplant recipients in the early and late posttransplant periods.
Soylu A; Kavukçu S; Türkmen MA; Kasap B; Soylu A; Bora S; Gülay H
Transplant Proc; 2006 Jun; 38(5):1286-9. PubMed ID: 16797283
[TBL] [Abstract][Full Text] [Related]
8. Hyperlipidemia in children after heart transplantation.
Singh TP; Naftel DC; Webber S; Dupuis J; Chin C; Spicer R; Schowengerdt KO; Ring WS; Morrow WR;
J Heart Lung Transplant; 2006 Oct; 25(10):1199-205. PubMed ID: 17045932
[TBL] [Abstract][Full Text] [Related]
9. Patient profile and effect of dietary therapy on post-transplant hyperlipidemia.
Shen SY; Lukens CW; Alongi SV; Sfeir RE; Dagher FJ; Sadler JH
Kidney Int Suppl; 1983 Dec; 16():S147-52. PubMed ID: 6376913
[TBL] [Abstract][Full Text] [Related]
10. Lipoprotein abnormalities in long-term stable liver and renal transplanted patients. A comparative study.
Fernández-Miranda C; de la Calle A; Morales JM; Guijarro C; Aranda JL; Gómez-Sanz R; Gómez-Izquierdo T; Larumbe S; Moreno E; Rodicio JL; del Palacio A
Clin Transplant; 1998 Apr; 12(2):136-41. PubMed ID: 9575402
[TBL] [Abstract][Full Text] [Related]
11. A long-term study of dyslipidemia and dyslipoproteinemia in stable post-renal transplant patients.
Kimak E; Solski J; Baranowicz-Gaszczyk I; Ksiazek A
Ren Fail; 2006; 28(6):483-6. PubMed ID: 16928617
[TBL] [Abstract][Full Text] [Related]
12. Lipid profiles in pediatric thoracic transplant recipients are determined by their immunosuppressive regimens.
Law YM; Yim R; Agatisa P; Boyle GJ; Miller SA; Lawrence K; Webber SA
J Heart Lung Transplant; 2006 Mar; 25(3):276-82. PubMed ID: 16507419
[TBL] [Abstract][Full Text] [Related]
13. Effect of oral fructose load on serum uric acid and lipids in kidney transplant recipients treated with cyclosporine or tacrolimus.
Zawiasa A; Szklarek-Kubicka M; Fijałkowska-Morawska J; Nowak D; Rysz J; Mamełka B; Nowicki M
Transplant Proc; 2009; 41(1):188-91. PubMed ID: 19249511
[TBL] [Abstract][Full Text] [Related]
14. Studies on eleven kidney transplants from non-heart-beating donors.
Marubayashi SM; Tashiro H; Ohdan H; Tokita D; Hara H; Onoe T; Kitayama T; Hayamizu K; Asahara T; Doi S; Okumoto S; Taniguchi Y; Fukuda Y; Dohi K
Hiroshima J Med Sci; 2004 Mar; 53(1):7-11. PubMed ID: 15274425
[TBL] [Abstract][Full Text] [Related]
15. Improved attainment of NKF classified lipid target levels after conversion from cyclosporine to tacrolimus in renal graft recipients.
Pohanka E; Margreiter R; Sparacino V; Sperschneider H;
Transplant Proc; 2005 May; 37(4):1874-6. PubMed ID: 15919490
[TBL] [Abstract][Full Text] [Related]
16. The long-term outcome of tacrolimus in cadaveric kidney transplantation from non-heart beating donors.
Fukuhara N; Ono Y; Hattori R; Nishiyama N; Yamada S; Kamihira O; Kinukawa T; Ohshima S
Clin Transplant; 2005 Apr; 19(2):153-7. PubMed ID: 15740548
[TBL] [Abstract][Full Text] [Related]
17. Lipoprotein pattern in end-stage renal disease and following successful renal transplantation.
Banyai-Falger S; Gottsauner-Wolf M; Stepan E; Strobl W; Jansen M; Heinz G; Hörl WH; Derfler K
Clin Transplant; 1997 Dec; 11(6):545-51. PubMed ID: 9408682
[TBL] [Abstract][Full Text] [Related]
18. New onset dyslipidemia after renal transplantation: is there a difference between tacrolimus and cyclosporine?
Deleuze S; Garrigue V; Delmas S; Chong G; Swarcz I; Cristol JP; Mourad G
Transplant Proc; 2006 Sep; 38(7):2311-3. PubMed ID: 16980075
[TBL] [Abstract][Full Text] [Related]
19. Sequential analysis of the lipid profile of children post-renal transplantation.
Singh A; Tejani C; Benfield M; Tejani A
Pediatr Transplant; 1998 Aug; 2(3):216-23. PubMed ID: 10084746
[TBL] [Abstract][Full Text] [Related]
20. Fluvastatin as co-medication in heart transplant recipients with elevated creatine-kinase.
Sadoni S; Kaczmarek I; Delgado O; Schmöckel M; Reichart B; Meiser B
Transplant Proc; 2007 Mar; 39(2):558-9. PubMed ID: 17362781
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
